$IOVA

$14.58 +$0.80 (5.81%) Close

$IOVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 453.0M shares outstanding

Who owns IOVA?

By type of holder

Institutions 62.4% Insiders 0.3% Everyone else 37.2%

Concentration Top 10 holders own 37.7%

BlackRock, Inc. 8.2% · MHR Fund Management LLC 6.4%

Institutional ownership

62.4%

+3.0 pts vs last qtr

Institutional holders

291

+5 vs last qtr

Net shares bought

+13.7M

by institutions in Q2 2026

New / sold out

45 / 40

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

State Street Corp +7.0M
BlackRock, Inc. +5.9M

Biggest sellers in Q2 2026

Invenomic Capital Management LP −7.0M
D. E. Shaw & Co., Inc. −5.9M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Iovance Biotherapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+187.4%

+19.24% a year

Each share's claim on the business

−65.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $453M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years61% 3–5 years15% 1–3 years17% Under 1 year7%

Quarterly turnover

16.9%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting IOVA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	37.0M	8.16%	+5.9M (+18.9%)	≤2021	0.0%
Shares held by quarter Peak holding37.0M (Q2'26) Change over 8 quarters+15.5M Share of the company8.160% BlackRock, Inc.'s full portfolio →
MF MHR Fund Management LLC	29.0M	6.39%	Unchanged	2022	6.3%
Shares held by quarter Peak holding29.0M (Q2'25) Change over 8 quarters+5.0M Share of the company6.390% MHR Fund Management LLC's full portfolio →

BlackRock, Inc.

37.0M

% of company

8.16%

Change vs last qtr

+5.9M (+18.9%)

Held since

≤2021

MHR Fund Management LLC

29.0M

% of company

6.39%

Change vs last qtr

Unchanged

Held since

2022

28 more super investors behind a free account

See every manager holding Iovance Biotherapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting IOVA on Form N-PORT; together they hold 22.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$60.3M	14.5M	3.20%	0.56%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$56.1M	13.5M	2.98%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$60.3M

% of company

3.20%

% of the fund

0.56%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$56.1M

% of company

2.98%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Iovance Biotherapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
VF Vogt Frederick G Insider	595.4K	0.13%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.130% Vogt Frederick G's insider activity →
PR Puri Raj K. Insider	256.4K	0.06%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.060% Puri Raj K.'s insider activity →

Vogt Frederick G

Insider

595.4K

% of company

0.13%

Change vs last qtr

—

Held since

—

Puri Raj K.

Insider

256.4K

% of company

0.06%

Change vs last qtr

—

Held since

—

7 more holders behind a free account

See every insider and 5%+ holder of Iovance Biotherapeutics Inc.

Comments